Stock Code: 002038 Stock Abbreviation: Shunglu Pharmaceutical Announcement Number: 2026-007
Beijing Shunglu Pharmaceutical Co., Ltd. Announcement on the Resignation of Directors and Election of Non-Independent Directors for the Ninth Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
I. Director Resignation
Beijing Shunglu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received a resignation report from Director Mr. Zhang Jiaqi on April 27, 2026. Mr. Zhang Jiaqi's term was originally set to expire at the end of the Ninth Board of Directors. Due to work adjustments, Mr. Zhang Jiaqi has applied to resign from his position as a director and member of relevant professional committees of the Company. After his resignation, Mr. Zhang Jiaqi will no longer hold any other positions in the Company and will not be employed by the Company or its subsidiaries. As of the date of this announcement, Mr. Zhang Jiaqi does not hold any shares in the Company. As Mr. Zhang Jiaqi's resignation will result in the number of members of the Ninth Board of Directors falling below the number stipulated in the Company's Articles of Association, Mr. Zhang Jiaqi will continue to perform his duties as a director of the Company and complete the relevant handover work in accordance with the Company Law, the Securities Law, and other relevant laws and regulations, as well as the Company's Articles of Association, until the shareholders' meeting elects new directors.
Mr. Zhang Jiaqi has performed his duties diligently and conscientiously during his tenure as a director of the Company. The Company expresses its sincere gratitude for his contributions to the development of the Company during his term.
II. Election of New Directors